A61L 2300/436
Of receptors
Official title: of receptors
A61L2300/436 (Of receptors) appears on 48 US grants and 131 published applications in this corpus.
Search patents in A61L- Granted patents
- 48
- Published applications
- 131
- Assignees
- 63
- Inventors
- 226
- Latest grant
- 14 Apr 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2000 | 1 | 0 |
| 2001 | 1 | 0 |
| 2002 | 1 | 3 |
| 2003 | 0 | 3 |
| 2004 | 0 | 3 |
| 2005 | 0 | 7 |
| 2006 | 0 | 2 |
| 2007 | 0 | 4 |
| 2008 | 1 | 6 |
| 2009 | 0 | 2 |
| 2010 | 0 | 2 |
| 2011 | 1 | 3 |
| 2012 | 3 | 5 |
| 2013 | 2 | 2 |
| 2014 | 2 | 3 |
| 2015 | 2 | 4 |
| 2016 | 3 | 11 |
| 2017 | 1 | 3 |
| 2018 | 3 | 5 |
| 2019 | 5 | 8 |
| 2020 | 4 | 12 |
| 2021 | 3 | 8 |
| 2022 | 2 | 13 |
| 2023 | 0 | 5 |
| 2024 | 7 | 8 |
| 2025 | 5 | 4 |
| 2026 | 1 | 5 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Drug delivery system and methods of using the same14 Apr 2026US 12,599,701 B2Axogen Corporation
- Compositions using iron excipients and their uses including for the treatment of cancer19 Aug 2025US 12,390,551 B2Zetagen Therapeutics, Inc.
- Compositions and methods for obtaining organoids29 Jul 2025US 12,370,222 B2Stemcell Technologies Canada Inc.
- Islet cell manufacturing compositions and methods of use20 May 2025US 12,304,900 B2Vertex Pharmaceuticals Incorporated
- Uniaxially-aligned nanofiber scaffolds and methods for producing and using same1 Apr 2025US 12,263,277 B2Oridivus LLC
- Target for combatting the foreign body response to implantable biomaterials1 Oct 2026US 2026/0295119 A1The Regents of the University of Colorado, a body corporate
- Composition for preventing or treating capsular contracture caused by implant surgery and use thereof1 Oct 2026US 2026/0295124 A1Soonchunhyang University Industry Academy Cooperation Foundation
- Drug delivery system and methods of using the same30 Jul 2026US 2026/0216403 A1Axogen Corporation
- Verteporfin Containing Silicone Topical Skin Adhesive for Wound Closure and Reduced Scarring30 Apr 2026US 2026/0115352 A1Cilag GmbH International
- Tissue regenerative multi-drug cocktail and apparatus for delivery thereof8 Jan 2026US 2026/0007720 A1Trustees of Tufts College
Most cited
By later US patents
- Drug delivery via therapeutic hydrogels154US 6,228,393 B1Uroteq Inc. · 2001
- Drug delivery via therapeutic hydrogels129US 6,132,765 AUroteq Inc. · 2000
- Drug delivery via therapeutic hydrogels85US 6,475,516 B22002
- Steroid-containing sustained release intraocular implants and related methods35US 8,147,865 B2Allergan, Inc. · 2012
- Compositions and methods of improved wound healing21US 10,434,142 B2Chan Soon-Shiong Nanthealth Foundation · 2019